Filter
493
Text search:
drug
regimens
Featured
Recommendations
57
New Publications
114
Language
Document type
No document type
313
Guidelines
67
Studies & Reports
64
Manuals
15
Strategic & Response Plan
13
Fact sheets
12
Training Material
6
Situation Updates
2
Online Courses
1
Countries / Regions
India
23
South Africa
15
Kenya
14
Western and Central Europe
14
Eastern Europe
12
Ethiopia
9
Ghana
9
Tanzania
9
Global
9
Nepal
8
Rwanda
8
Zambia
7
Africa
7
Uganda
6
Bangladesh
6
Ukraine
6
Nigeria
5
Zimbabwe
5
Myanmar / Burma
5
South–East Asia Region
5
Latin America and the Carribbean
5
Asia
5
Philippines
4
Malawi
4
Russia
4
Cameroon
3
Cambodia
3
Namibia
3
Sierra Leone
2
Tajikistan
2
USA
1
Somalia
1
Pakistan
1
Afghanistan
1
Germany
1
Thailand
1
Mozambique
1
Papua New Guinea
1
Argentina
1
Eswatini/ Swaziland
1
Colombia
1
Lesotho
1
Sri Lanka
1
East and Southern Africa
1
West and Central Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Bhutan
1
Venezuela
1
Albania
1
Estonia
1
Georgia
1
Vietnam
1
Denmark
1
Authors & Publishers
Publication Years
Category
Countries
145
Clinical Guidelines
84
Women & Child Health
22
Public Health
20
Capacity Building
6
Key Resources
6
Pharmacy & Technologies
3
Toolboxes
TB
113
HIV
105
NTDs
20
AMR
19
Pharmacy
17
Mental Health
11
NCDs
10
Refugee
7
COVID-19
6
Conflict
5
Caregiver
5
Disability
4
Polio
4
Malaria
4
Ebola & Marburg
3
Natural Hazards
3
Rapid Response
3
Specific Hazards
1
The results of the SHINE trial have been published in the NEJM today. SHINE looked at whether treatment for children with minimal TB could be reduced from 6 months to 4 months. It found that the four month treatment was as good as the standard six months treatment for children with minimal TB
The Lancet Volume 5, Issue 10100972October 2024 Chagas Disease Serie 3
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
National Tuberculosis and Leprosy Conrol Programme
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affordability, geographical accessibility, quality and r
...